Results

Roche Holding AG

10/13/2021 | Press release | Distributed by Public on 10/12/2021 23:02

Data up to 8-years for Roche’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and[...]